Integrase strand transfer inhibitor (InSTI) resistance rates are low. However, genotypic
resistance test (GRT) is not routinely performed in many centers. The aim of this study is to …

Objectives The aim of the study was to analyse the prevalence of integrase resistance
mutations in integrase strand transfer inhibitor (INSTI)‐experienced HIV‐1‐infected patients …

Background and Objective: Integrase strand transfer inhibitors (INSTIs) are currently the
standard of practice for first-line HIV therapy for most patients. We evaluated the mutations …

Objectives This study evaluated the emergence of mutations associated with integrase
strand transfer inhibitors (INSTI) resistance (INSTI-RMs) and the integrase evolution in …

There has been no systematic review of the prevalence of transmitted integrase strand
transfer inhibitor (INSTI) resistance. We systematically searched the English-language …

Objectives: Integrase strand transfer inhibitor (INSTI) is a new class of antiretroviral (ARV)
drugs designed to block the action of the integrase viral enzyme, which is responsible for …

Reports of resistance to integrase strand transfer inhibitors (INSTIs) are now not uncommon.
We analyzed the HIV int gene from plasma of antiretroviral-naïve individuals during acute …

Objectives To describe integrase strand transfer inhibitor (INSTI) resistance profiles and
factors associated with resistance in antiretroviral-naive and-experienced patients failing an …

Updated guidelines for the treatment of antiretroviral therapy (ART)-negative patients with
HIV recommend integrase strand transfer inhibitor (INSTI)-based regimens. HIV patients are …

Antiretroviral therapy containing an integrase strand transfer inhibitor (INSTI) plus two NRTIs
has become the recommended treatment for antiretroviral-naive HIV-1-infected patients in …